271 related articles for article (PubMed ID: 2840075)
61. Expression of c-kit protooncogene is stimulated by cAMP in differentiated F9 mouse teratocarcinoma cells.
Nishina Y; Kobarai Y; Sumi T; Kosaka M; Nishikawa S; Nishimune Y
Exp Cell Res; 1992 Feb; 198(2):352-6. PubMed ID: 1370268
[TBL] [Abstract][Full Text] [Related]
62. Reduced expression of PLC-gamma during the differentiation of mouse F9 teratocarcinoma cells.
Lee YH; Lee HY; Ryu SH; Suh PG; Kim KW
Cancer Lett; 1993 Feb; 68(2-3):237-42. PubMed ID: 8383002
[TBL] [Abstract][Full Text] [Related]
63. Decreased c-myc expression is an early event in retinoic acid-induced differentiation of F9 teratocarcinoma cells.
Griep AE; DeLuca HF
Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5539-43. PubMed ID: 3526333
[TBL] [Abstract][Full Text] [Related]
64. Production of immunoreactive calcitonin and parathyroid hormone by embryonal carcinoma cells: alteration with retinoic acid-induced differentiation.
Evain-Brion D; Binet E; Donnadieu M; Laurent P; Anderson WB
Dev Biol; 1984 Aug; 104(2):406-12. PubMed ID: 6745491
[TBL] [Abstract][Full Text] [Related]
65. High expression of stathmin in multipotential teratocarcinoma and normal embryonic cells versus their early differentiated derivatives.
Doye V; Kellermann O; Buc-Caron MH; Sobel A
Differentiation; 1992 Jun; 50(2):89-96. PubMed ID: 1323493
[TBL] [Abstract][Full Text] [Related]
66. Proteoglycan-19, laminin and collagen type IV production is correlated with the levels of mRNA in F9 cell aggregates differentiating in the presence or absence of cyclic AMP.
Grover A; Edwards SA; Bourdon M; Adamson ED
Differentiation; 1987; 36(2):138-44. PubMed ID: 2834254
[TBL] [Abstract][Full Text] [Related]
67. Accelerated biosynthesis of neolacto-series glycosphingolipids in differentiated mouse embryonal carcinoma F9 cells detected by using dodecyl N-acetylglucosaminide as a saccharide primer.
Ogasawara N; Katagiri YU; Kiyokawa N; Kaneko T; Sato B; Nakajima H; Miyagawa Y; Kushi Y; Ishida H; Kiso M; Okita H; Sato T; Fujimoto J
J Biochem; 2011 Mar; 149(3):321-30. PubMed ID: 21148159
[TBL] [Abstract][Full Text] [Related]
68. Thrombomodulin gene regulation by cAMP and retinoic acid in F9 embryonal carcinoma cells.
Weiler-Guettler H; Yu K; Soff G; Gudas LJ; Rosenberg RD
Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2155-9. PubMed ID: 1312715
[TBL] [Abstract][Full Text] [Related]
69. A new differentiated cell line (Dif 5) derived by retinoic acid treatment of F9 teratocarcinoma cells capable of extracellular matrix production and growth in the absence of serum.
Nagarajan L; Jetten AM; Anderson WB
Exp Cell Res; 1983 Sep; 147(2):315-27. PubMed ID: 6193979
[TBL] [Abstract][Full Text] [Related]
70. Expression of transforming growth factor-beta 3 by embryonal carcinoma cells, parietal endoderm-like cells and early mouse embryos.
Campbell WJ; Kelly D; Rizzino A
In Vitro Cell Dev Biol; 1990 Dec; 26(12):1181-5. PubMed ID: 1964159
[TBL] [Abstract][Full Text] [Related]
71. Defective post-translational modification of collagen IV in a mutant F9 teratocarcinoma cell line is associated with delayed differentiation and growth arrest in response to retinoic acid.
Wang SY; Roguska MA; Gudas LJ
J Biol Chem; 1989 Sep; 264(26):15556-64. PubMed ID: 2549067
[TBL] [Abstract][Full Text] [Related]
72. Characterization of the mouse thrombomodulin gene and functional analysis of the 5' flanking region in F9 teratocarcinoma cells.
Niforas P; Sanderson GM; Bird CH; Bird P
Biochim Biophys Acta; 1993 May; 1173(2):179-87. PubMed ID: 8389207
[TBL] [Abstract][Full Text] [Related]
73. Expression of SPARC is correlated with altered morphologies in transfected F9 embryonal carcinoma cells.
Everitt EA; Sage EH
Exp Cell Res; 1992 Mar; 199(1):134-46. PubMed ID: 1310471
[TBL] [Abstract][Full Text] [Related]
74. Molecular cloning of complementary DNA to mouse tissue plasminogen activator mRNA and its expression during F9 teratocarcinoma cell differentiation.
Rickles RJ; Darrow AL; Strickland S
J Biol Chem; 1988 Jan; 263(3):1563-9. PubMed ID: 2826484
[TBL] [Abstract][Full Text] [Related]
75. Retinoic acid induces liver/bone/kidney-type alkaline phosphatase gene expression in F9 teratocarcinoma cells.
Gianni M; Studer M; Carpani G; Terao M; Garattini E
Biochem J; 1991 Mar; 274 ( Pt 3)(Pt 3):673-8. PubMed ID: 1849403
[TBL] [Abstract][Full Text] [Related]
76. Post-transcriptional control of myc and p53 expression during differentiation of the embryonal carcinoma cell line F9.
Dony C; Kessel M; Gruss P
Nature; 1985 Oct 17-23; 317(6038):636-9. PubMed ID: 2414665
[TBL] [Abstract][Full Text] [Related]
77. Lack of correlation between loss of anchorage-independent growth and levels of transformation-specific p53 protein in retinoic acid-treated F9 embryonal carcinoma cells.
Rodrigues M; Balicki D; Newrock KM; Mukherjee BB
Exp Cell Res; 1985 Jan; 156(1):22-30. PubMed ID: 2981174
[TBL] [Abstract][Full Text] [Related]
78. Identification of a major poly-N-acetyllactosamine-containing cell-surface glycoprotein of mouse teratocarcinoma cells. Appearance on cells induced to primitive endoderm but not parietal endoderm differentiation.
Spillmann D; Finne J
Eur J Biochem; 1994 Mar; 220(2):385-94. PubMed ID: 8125095
[TBL] [Abstract][Full Text] [Related]
79. Characterization of cytosolic calcium-activated phospholipid-dependent protein kinase activity in embryonal carcinoma cells. Effect of retinoc acid-induced differentiation of F9 cells to parietal endoderm.
Kraft AS; Anderson WB
J Biol Chem; 1983 Aug; 258(15):9178-83. PubMed ID: 6874683
[TBL] [Abstract][Full Text] [Related]
80. Early increase in histone H1(0) mRNA during differentiation of F9 cells to parietal endoderm.
Alonso A; Breuer B; Bouterfa H; Doenecke D
EMBO J; 1988 Oct; 7(10):3003-8. PubMed ID: 2846273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
